Class ITerminatedVoluntary: Firm initiated

COREPACK MANUFACTURING INC: food recall F-0530-2025

COREPACK MANUFACTURING INC of Orem, UT recalled White Maeng da, kratom powder product packaged mylar resealable bags. 3 oz package, 80 bags per shipper box. Reason: Possible Salmonella contamination of affected product. The FDA listed it as Class I in its Enforcement Report dated Feb 12, 2025; distribution: nationwide.

Record status as published: Terminated (terminated Jun 20, 2025). openFDA data last updated Oct 21, 2026.

Have this product? Check FDA.gov and your retailer. This page reproduces an FDA Enforcement Report record and is not a public alert. Look for the firm's recall notice on the FDA's recalls page, or ask the store where you bought it what to do. If you think you got sick from a food, contact a health care provider.

Recall details

Product
White Maeng da, kratom powder product packaged mylar resealable bags. 3 oz package, 80 bags per shipper box.
Product quantity
5520 units
Reason for recall
Possible Salmonella contamination of affected product.
Codes, lots and dates on the package
Lot #CP11122, Expired April 2024--not included on label--
Distribution pattern
Throughout the United States.
Recalling firm
COREPACK MANUFACTURING INC, Orem, UT
Classification
Class I — the FDA uses this class for a situation in which there is a reasonable probability that using or being exposed to the product will cause serious adverse health consequences or death.
Voluntary or mandated
Voluntary: Firm initiated
How the firm first notified customers
Letter

Dates

EventDate
Recall initiated by the firmDec 12, 2024
Classified by the FDAFeb 5, 2025
Published in the Enforcement ReportFeb 12, 2025
TerminatedJun 20, 2025

All food recall records

OpenPlate shows FDA records as published and does not add new findings. Product names and company names belong to their owners.

Sources

  • U.S. Food and Drug Administration, openFDA food enforcement reports, recall number F-0530-2025 (openFDA record). Data provided by the U.S. Food and Drug Administration (https://open.fda.gov).
  • Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service. The FDA does not endorse OpenPlate.